Analysts forecast that LifePoint Health, Inc. (NASDAQ:LPNT) will announce $1.60 billion in sales for the current quarter, according to Zacks. Eight analysts have issued estimates for LifePoint Health’s earnings, with the lowest sales estimate coming in at $1.58 billion and the highest estimate coming in at $1.61 billion. LifePoint Health posted sales of $1.59 billion in the same quarter last year, which suggests a positive year over year growth rate of 0.6%. The firm is scheduled to announce its next earnings results before the market opens on Friday, October 27th.

According to Zacks, analysts expect that LifePoint Health will report full year sales of $1.60 billion for the current fiscal year, with estimates ranging from $6.43 billion to $6.49 billion. For the next financial year, analysts expect that the business will report sales of $6.61 billion per share, with estimates ranging from $6.48 billion to $6.72 billion. Zacks Investment Research’s sales calculations are an average based on a survey of analysts that follow LifePoint Health.

LifePoint Health (NASDAQ:LPNT) last posted its quarterly earnings data on Tuesday, August 1st. The company reported $0.96 EPS for the quarter, topping the consensus estimate of $0.90 by $0.06. The firm had revenue of $1.59 billion during the quarter, compared to analyst estimates of $1.64 billion. LifePoint Health had a return on equity of 7.40% and a net margin of 2.61%. LifePoint Health’s revenue was up .2% on a year-over-year basis. During the same period in the prior year, the business posted $0.69 EPS.

Several research firms have recently commented on LPNT. BidaskClub upgraded shares of LifePoint Health from a “hold” rating to a “buy” rating in a research report on Friday, June 30th. Royal Bank Of Canada reiterated a “buy” rating and issued a $77.00 price objective on shares of LifePoint Health in a research report on Wednesday, July 5th. Zacks Investment Research upgraded shares of LifePoint Health from a “hold” rating to a “buy” rating and set a $75.00 price objective for the company in a research report on Tuesday, July 4th. Piper Jaffray Companies reiterated a “hold” rating and issued a $66.00 price objective on shares of LifePoint Health in a research report on Wednesday, October 4th. Finally, ValuEngine downgraded shares of LifePoint Health from a “buy” rating to a “hold” rating in a research report on Friday, September 1st. Four research analysts have rated the stock with a sell rating, eleven have issued a hold rating and three have given a buy rating to the stock. LifePoint Health has an average rating of “Hold” and an average price target of $65.54.

LifePoint Health (LPNT) opened at 58.35 on Monday. The stock’s 50 day moving average price is $56.59 and its 200-day moving average price is $60.79. The stock has a market cap of $2.34 billion, a price-to-earnings ratio of 13.07 and a beta of 0.84. LifePoint Health has a 12 month low of $50.60 and a 12 month high of $70.95.

A number of institutional investors have recently added to or reduced their stakes in the business. Teacher Retirement System of Texas lifted its holdings in LifePoint Health by 0.3% during the 2nd quarter. Teacher Retirement System of Texas now owns 3,211 shares of the company’s stock worth $216,000 after buying an additional 9 shares in the last quarter. US Bancorp DE lifted its holdings in LifePoint Health by 0.8% during the 2nd quarter. US Bancorp DE now owns 1,947 shares of the company’s stock worth $130,000 after buying an additional 16 shares in the last quarter. Commonwealth of Pennsylvania Public School Empls Retrmt SYS lifted its holdings in LifePoint Health by 1.0% during the 2nd quarter. Commonwealth of Pennsylvania Public School Empls Retrmt SYS now owns 5,891 shares of the company’s stock worth $396,000 after buying an additional 56 shares in the last quarter. Meeder Asset Management Inc. lifted its holdings in LifePoint Health by 0.6% during the 2nd quarter. Meeder Asset Management Inc. now owns 13,547 shares of the company’s stock worth $909,000 after buying an additional 76 shares in the last quarter. Finally, Zurcher Kantonalbank Zurich Cantonalbank lifted its holdings in LifePoint Health by 10.8% during the 2nd quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 1,678 shares of the company’s stock worth $113,000 after buying an additional 164 shares in the last quarter. Institutional investors own 99.53% of the company’s stock.

ILLEGAL ACTIVITY WARNING: This piece of content was posted by American Banking News and is the sole property of of American Banking News. If you are viewing this piece of content on another publication, it was stolen and republished in violation of US & international copyright & trademark law. The original version of this piece of content can be viewed at https://www.americanbankingnews.com/2017/10/23/brokerages-expect-lifepoint-health-inc-lpnt-will-post-quarterly-sales-of-1-60-billion.html.

About LifePoint Health

LifePoint Health, Inc, through its subsidiaries, owns and operates community hospitals, regional health systems, physician practices, outpatient centers and post-acute facilities. As of December 31, 2016, the Company operated 72 hospital campuses in 22 states, having a total of 9,424 licensed beds. It offers a range of general and specialized healthcare services to patients through a network of hospitals and outpatient facilities.

Get a free copy of the Zacks research report on LifePoint Health (LPNT)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for LifePoint Health (NASDAQ:LPNT)

Receive News & Ratings for LifePoint Health Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LifePoint Health Inc. and related companies with MarketBeat.com's FREE daily email newsletter.